Global Epinephrine Revenue Market Was Valued At 2246.25 M USD In 2017
Tuesday, 23 Oct, 2018
The global revenue of Epinephrine market was valued at 2246.25 M USD in 2017 and is expected to reach USD 3897.80 M USD in 2025. In the future five years, we predict the CAGR of global revenue is 7.13%.

United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017. 

In the industry, Mylan Inc profits most in 2016 and recent years, while Impax and ALK Abello ranked 2 and 3.The market share of them is 52.75%, 4.37% and 2.64% in 2017.The gap of market share is keep on enlarged due to different strategy.

Nowadays, there are three mainly types of Epinephrine, including Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products. And Epinephrine Auto-injector is the main type for Epinephrine, and the Epinephrine Auto-injector reached a sales value of approximately 1430.61 M  USD in 2017, with 63.69% of global sales value.

Epinephrine technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.